Number of patients by maximum CRS grade by Lee scale who did or did not receive tocilizumab in the JULIET and ZUMA-1 trials. JULIET: Of the 16 patients who received tocilizumab in JULIET, 6 patients received 1 dose and 10 patients received 2 doses. ZUMA-1: Of the 49 patients who received tocilizumab in ZUMA-1, 30 patients received 1 dose, 13 patients received 2 doses, 2 patients received 3 doses, 2 patients received 4 doses, and 2 patients received 5 doses.